Facts, fancies and follies of drug-induced QT/QTc interval shortening

British Journal of Pharmacology

Volumn 159, Issue 1, 2010, Pages 70-76

  Malik, Marek ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; NEW DRUG; PLACEBO;

CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HEART ARRHYTHMIA; HEART FAILURE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; NOTE; POTASSIUM CURRENT; PREVALENCE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SHORT QT INTERVAL; TORSADE DES POINTES;

DRUG DESIGN; ELECTROCARDIOGRAPHY; HUMANS; LEGISLATION, DRUG; LONG QT SYNDROME; PHARMACEUTICAL PREPARATIONS; TORSADES DE POINTES;

EID: 74549154396     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00554.x     Document Type: Note

References (49)

1. Ahnve S (1985). QT interval prolongation in acute myocardial infarction. Eur Heart J 6 : 85 95.
2. Asami T, Suzuki H, Yazaki S, Sato S, Uchiyama M (2001). Effects of thyroid hormone deficiency on electrocardiogram findings of congenitally hypothyroid neonates. Thyroid 11 : 765 768.
3. Baig MK, Goldman JH, Caforio AL, Coonar AS, Keeling PJ, McKenna WJ (1998). Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 31 : 195 201.
4. Breidthardt T, Christ M, Matti M, Schrafl D, Laule K, Noveanu M et al. (2007). QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart 93 : 1093 1097.
5. Codd MB, Sugrue DD, Gersh BJ, Melton LJ (1989). Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation 80 : 564 572.
6. Davidenko JM, Cohen L, Goodrow R, Antzelevitch C (1989). Quinidine-induced action potential prolongation, early after depolarizations, and triggered activity in canine Purkinje fibers: effects of stimulation rate, potassium, and magnesium. Circulation 79 : 674 686.
7. DeWitt CR, Waksman JC (2004). Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 23 : 223 238.
8. TM (rufinamide). Product information. http://www.banzel.com/Docs/Pdf/BanzelPI.pdf [accessed on 13 September 2009].
9. Garberoglio L, Giustetto C, Wolpert C, Gaita F (2007). Is acquired short QT due to digitalis intoxication responsible for malignant venticular arrhythmias?. J Electrocardiol 40 : 43 46.
10. Gheorghiade M, Adams KFJ, Colucci WS (2004). Digoxin in the management of cardiovascular disorders. Circulation 109 : 2959 2964.
11. Hohnloser SH, Klingenheben T, Singh BN (1994). Amiodarone-associated proarrhythmic effects: a review with special reference to Torsade de Pointes tachycardia. Ann Intern Med 121 : 529 535.
12. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR (1993). Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA 269 : 1513 1518.
13. ICH (2005). International Conference on Harmonization ICH Note for Guidance on the Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs (ICH E14). http://www.fda.gov/RegulatoryInformation/Guidances/ucm129335.htm [accessed on 11 July 2009 C, Round AD, Lyon LL, Terdiman JF, Stang PD (2009). Descriptive epidemiology of short QT interval in a cohort of 1.7 million persons. Eur Heart J 30 : Abst suppl 697.
14. Jenzer HR, Hagemeijer F (1976). Quinidine syncope: Torsade de Pointes with low quinidine plasma concentrations. Eur J Cardiol 4 : 447 451.
15. Jordaens L, de Pauw M, Caes F (1996). Familial dilated cardiomyopathy and spontaneous ventricular arrhythmias. Am J Cardiol 78 : 102 104.
16. Kolo PM, Opadijo OG, Omotoso AB, Balogun MO, Araoye MA, Katibi IA (2008). Prevalence of QTc prolongation in adult Nigerians with chronic heart failure. West Afr J Med 27 : 69 73.
17. Lim HE, Pak HN, Ahn JC, Song WH, Kim YH (2006). Torsade de Pointes induced by short-term oral amiodarone therapy. Europace 8 : 1051 1053.
18. Madias JE (2007). The resting electrocardiogram in the management of patients with congestive heart failure: established applications and new insights. Pacing Clin Electrophysiol 30 : 123 128.
19. Malik M (2002). The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes. Pacing Clin Electrophysiol 25 : 209 216.
20. Malik M (2003). Drug-induced QT interval prolongation - why is it of concern? http://www.fda.gov/ohrms/dockets/ac/03/slides/4000S1-05-Malik-files/ frame.htm [accessed on 13 September 2009].
21. Malik M (2009). Drug-induced changes in the T-wave morphology. Drug Saf 32 : 613 617.
22. Malik M, Camm AJ (2001). Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf 24 : 323 351.
23. Malik M, Hnatkova H, Schmidt A, Smetana P (2009). Electrocardiographic QTc changes due to moxifloxacin infusion. J Clin Pharmacol 49 : 674 683.
24. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV et al. (1992). Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 69 : 1458 1466.
25. Omran MA, Abdel-Nabi IM (1997). Changes in the arterial blood pressure, heart rate and normal ECG parameters of rat after envenomation with Egyptian cobra (Naja haje) venom. Hum Exp Toxicol 16 : 327 333.
26. Pelliccia F, Critelli G, Cianfrocca C, Nigri A, Reale A (1991). Electrocardiographic correlates with left ventricular morphology in idiopathic dilated cardiomyopathy. Am J Cardiol 68 : 642 647.
27. Perna GP, Valle G, Cianfrone N, Luca GD, Amico C, Coli C (1998). Amlodipine in ischaemic left ventricular dysfunction with mild to moderate heart failure. Clin Drug Investig 16 : 289 296.
28. Pinto YM, van Gelder IC, Heeringa M, Crijns HJ (1999). QT lengthening and life-threatening arrhythmias associated with fexofenadine. Lancet 353 : 980. (Pubitemid 29132610)
29. Pratt C, Brown AM, Rampe D, Mason J, Russell T, Reynolds R et al. (1999). Cardiovascular safety of fexofenadine HCl. Clin Exp Allergy 29 (Suppl. 3 212 216. (Pubitemid 29333360)
30. Rautaharju PM, Zhang ZM (2002). Linearly scaled, rate-invariant normal limits for QT interval: eight decades of incorrect application of power functions. J Cardiovasc Electrophysiol 13 : 1211 1218.
31. Reinig MG, Engel TR (2007). The shortage of short QT intervals. Chest 132 : 246 249.
32. Roden DM, Woosley RL, Primm RK (1986). Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 111 : 1088 1093.
33. Sandusky GE Jr., Meyers DB (1985). Toxicology of indecainide hydrochloride in mice, rats, and dogs. Fundam Appl Toxicol 5 : 175 181.
34. Saner HE, Pierach CA, Aeppli DM (1988). Relation between serum digoxin concentration and the electrocardiogram. Clin Cardiol 11 : 752 756.
35. Saumarez RC, Grace AA (2000). Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc Res 47 : 11 22.
36. Selzer A, Wray HW (1964). Quinidine syncope. Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation 30 : 17 26.
37. Shah RR (2010). Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives. Br J Pharmacol 159 : 58 69.
38. Teh HS, Tan HJ, Loo CY, Raymond AA (2007). Short QTc in epilepsy patients without cardiac symptoms. Med J Malaysia 62 : 104 108.
39. Tepel M, Hopfenmueller W, Scholze A, Maier A, Zidek W (2008). Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients. Nephrol Dial Transplant 23 : 3605 3612.
40. Tran HT, Chow MS, Kluger J (1997). Amiodarone induced Torsades de Pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia. Pacing Clin Electrophysiol 20 : 2275 2278.
41. Viskin S, Zeltser D, Ish-Shalom M, Katz A, Glikson M, Justo D et al. (2004). Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm 1 : 587 591.
42. Voiculescu M, Ionescu C, Ismail G (2006). Frequency and prognostic significance of QT prolongation in chronic renal failure patients. Rom J Intern Med 44 : 407 417.
43. Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Radovancevic B (2005). Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. J Card Fail 11 : 684 690.
44. Watanabe T, Kubota I, Yamaki M, Tachibana H, Tomoike H (1999). Direct effects of class I antiarrhythmic drugs on epicardial electrograms in dogs. Jpn Heart J 40 : 621 628.
45. Watanabe E, Arakawa T, Uchiyama T, Tong M, Yasui K, Takeuchi H et al. (2007). Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart Rhythm 4 : 999 1005.
46. Xie RQ, Cui W, Liu F, Yang C, Pei WN, Lu JC (2009). Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure. Int J Cardiol Epub ahead of print] doi:10.1016/j.ijcard.2008.11.030.
47. Yamada S, Kuga K, Yamaguchi I (2001). Torsade de Pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy. Jpn Circ J 65 : 236 238.
48. Zalinas R, Brazdzionyte J, Zabiela V, Jurkevicius R (2005). Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction. Int J Cardiol 101 : 347 353.
49. Zareba W, Cygankiewicz I (2008). Long QT syndrome and short QT syndrome. Prog Cardiovasc Dis 51 : 264 278.